In multiple sclerosis, an impairment of the glymphatic system may contribute to pathology accrual in the central nervous system and disability progression.

Baseline characteristics of Aβ-positive individuals can help identify those who will remain tau-negative for at least 5 years.

Greater diffusion restriction in the white matter of amyloid-beta-positive cognitively unimpaired individuals supports the role of inflammation in early preclinical AD.

New Neurology Update from Stroke Scientific Panel

To mark World Alzheimer Day on 21 September, Alzheimer Europe launched a new initiative called ‘What Makes You, You?’

The revised Boston criteria allow for a more accurate diagnosis of cerebral amyloid angiopathy

WGS can reliably assess the most common neurological disease-causing repeat expansions, further supporting its implementation in clinical practice.

New Neurology Update from Palliative Care is in! Read more about the topics here

The Brain Innovation Days are fast approaching, taking place in Brussels on 11-12 October 2022.

Read the latest reports from EAN Clinical Fellowship participants on their experiences in Innsbruck and London.

The EAN Guideline Production Group has developed a template for EAN guideline protocols, to facilitate production of high quality guidelines.

26th Conference of the European Society of Neurosonology and Cerebral Hemodynamics (ESNCH) October 14-16, 2022 Neurosonology 2022 will mark the return of fully presential meetings to the main worldwide event in Neurosonology, representing a unique opportunity to share knowledge. The… Continue Reading

Dr. Martin Rakusa speaks to Profs. Kristian Steen Frederiksen and Flavio Nobili, co-chairs of the EAN Scientific Panel on Dementia and Cognitive Disorders.

In summer 2022 EAN introduced a new membership benefit for Student Members: the option to join the EAN Scientific & Coordinating Panels.

Our highlighted selection of recent Covid-related case series or case reports from the scientific press for September 2022.